Free Trial
NASDAQ:XBIT

XBiotech (XBIT) Stock Price, News & Analysis

XBiotech logo
$3.02 -0.01 (-0.17%)
As of 12:01 PM Eastern
This is a fair market value price provided by Polygon.io. Learn more.

About XBiotech Stock (NASDAQ:XBIT)

Key Stats

Today's Range
$3.03
$3.07
50-Day Range
$2.50
$3.22
52-Week Range
$2.50
$8.32
Volume
5,003 shs
Average Volume
68,182 shs
Market Capitalization
$92.23 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

XBiotech Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
9th Percentile Overall Score

XBIT MarketRank™: 

XBiotech scored higher than 9% of companies evaluated by MarketBeat, and ranked 891st out of 922 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    There is not enough analysis data for XBiotech.

  • Price to Earnings Ratio vs. the Market

    The P/E ratio of XBiotech is -2.36, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of XBiotech is -2.36, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Book Value per Share Ratio

    XBiotech has a P/B Ratio of 0.51. P/B Ratios below 1 indicate that a company could be undervalued with respect to its assets and liabilities.

  • Read more about XBiotech's valuation and earnings.
  • Percentage of Shares Shorted

    5.11% of the float of XBiotech has been sold short.
  • Short Interest Ratio / Days to Cover

    XBiotech has a short interest ratio ("days to cover") of 17.9, which indicates bearish sentiment.
  • Change versus previous month

    Short interest in XBiotech has recently increased by 28.43%, indicating that investor sentiment is decreasing significantly.
  • Dividend Yield

    XBiotech does not currently pay a dividend.

  • Dividend Growth

    XBiotech does not have a long track record of dividend growth.

  • Percentage of Shares Shorted

    5.11% of the float of XBiotech has been sold short.
  • Short Interest Ratio / Days to Cover

    XBiotech has a short interest ratio ("days to cover") of 17.9, which indicates bearish sentiment.
  • Change versus previous month

    Short interest in XBiotech has recently increased by 28.43%, indicating that investor sentiment is decreasing significantly.
  • News Sentiment

    XBiotech has a news sentiment score of 0.59. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This news sentiment score is similar to the average news sentiment of Medical companies.
  • News Coverage This Week

    MarketBeat has tracked 1 news article for XBiotech this week, compared to 0 articles on an average week.
  • MarketBeat Follows

    1 people have added XBiotech to their MarketBeat watchlist in the last 30 days.
  • Insider Buying vs. Insider Selling

    In the past three months, XBiotech insiders have not sold or bought any company stock.

  • Percentage Held by Insiders

    33.10% of the stock of XBiotech is held by insiders. A high percentage of insider ownership can be a sign of company health.

  • Percentage Held by Institutions

    55.70% of the stock of XBiotech is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

  • Read more about XBiotech's insider trading history.
Receive XBIT Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for XBiotech and its competitors with MarketBeat's FREE daily newsletter.

XBIT Stock News Headlines

This Signal Only Flashes Once Every 4 Years – And It Just Triggered
This same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in crypto. Now it’s back, and the smart money is already positioning. A free training reveals the step-by-step strategy and altcoin picks designed to help you capitalize on the next wave.
See More Headlines

XBIT Stock Analysis - Frequently Asked Questions

XBiotech's stock was trading at $3.95 at the start of the year. Since then, XBIT shares have decreased by 23.0% and is now trading at $3.04.

XBiotech Inc. (NASDAQ:XBIT) posted its quarterly earnings data on Wednesday, May, 14th. The biopharmaceutical company reported ($0.36) earnings per share for the quarter.

XBiotech (XBIT) raised $76 million in an initial public offering (IPO) on Wednesday, April 15th 2015. The company issued 4,000,000 shares at a price of $18.00-$20.00 per share. WR Hambrecht + Co acted as the underwriter for the IPO.

Shares of XBIT stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that XBiotech investors own include Voyager Therapeutics (VYGR), American Water Works (AWK), The RMR Group (RMR), Waste Connections (WCN), DiamondRock Hospitality (DRH), iShares Micro-Cap ETF (IWC) and AU Optronics (AUOTY).

Company Calendar

Last Earnings
5/14/2025
Today
7/09/2025
Next Earnings (Estimated)
8/11/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
MED - BIOMED/GENE
Sub-Industry
Pharmaceutical Products
Current Symbol
NASDAQ:XBIT
CIK
1626878
Employees
100
Year Founded
N/A

Profitability

Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$38.53 million
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
$4.01 million
Price / Cash Flow
N/A
Book Value
$5.98 per share
Price / Book
0.51

Miscellaneous

Free Float
20,396,000
Market Cap
$92.14 million
Optionable
Optionable
Beta
0.98

Social Links

These 7 Stocks Will Be Magnificent in 2025 Cover

Discover the next wave of investment opportunities with our report, 7 Stocks That Will Be Magnificent in 2025. Explore companies poised to replicate the growth, innovation, and value creation of the tech giants dominating today's markets.

Get This Free Report

This page (NASDAQ:XBIT) was last updated on 7/9/2025 by MarketBeat.com Staff
From Our Partners